Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Continuing Education and Accreditation
Division of Learning and Organizational Development Center for Drug Evaluation and Research
Notice of Reorganization
The FDA's accredited Continuing Education program has been impacted by the reorganization of HHS and FDA, which took effect April 1, 2025. There are currently no staff available to process applications or continuing education credit.
For any staff remaining with FDA, please reach out directly to your supervisor for guidance on any future training events/activities for professional development and continuing education credits. For members of the public, please see www.fda.gov for updates.
Reporting and Public Viewing of Individual Case Safety Reports (ICSRs)
Credit Claiming Deadline Expired
Step
Status
Educational Content
✘
Posttest
✘
Evaluation
✘
Starts On:
Thu, 6/23/22: 12:00 AM EDT
Ends On:
Tue, 5/13/25: 12:00 AM EDT
Type:
Enduring Material
Credits:
1
Description:
The purpose of this webinar is to understand the reporting of Individual Case Safety Reports (ICSRs) to FDA and learn how to access and view the publicly available data in the FDA Adverse Event Reporting System (FAERS). This session also will focus on understanding data issues encountered in ICSRs and providing tips and methods to improve data quality.
Objectives:
Explain how to utilize FDA's Drug Information, medication safety resources, and regulatory guidances to improve delivery of patient care and optimize outcomes.
Describe and inform health care providers of recent labeling, policy and regulatory changes which would impact prescribing and medication management to optimize patient care.
Additional Information:
Review the Activity Announcement for additional details: Announcement Form